Inventor · disambiguated record
Xavier Ligneau
Also filed as: LIGNEAU XAVIER
19 granted patents·3 pending applications·124 citations·filing 1996–2022
93Inventor score
Files withBIOPROJET SOC CIV10CAPET MARC2ILE BIOPROJET SOC CIV2BERREBI-BERTRAND ISABELLE1BERTRAND ISABELLE1
Top patents by PatentIndex Score
22 records- 0189US9255101B26,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligandsBIOPROJECT·Filed 2013·Granted Feb 9, 2016·25 cites·13 claims
- 0284US7910605B2Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applicationsILE BIOPROJET SOC CIV·Filed 2006·Granted Mar 22, 2011·8 cites·6 claims
- 0383US8207197B2Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidineRAGA MANUEL·Filed 2006·Granted Jun 26, 2012·12 cites·10 claims
- 0483US7169928B2Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applicationsBIOPROJECT SOC CIV·Filed 2004·Granted Jan 30, 2007·17 cites·17 claims
- 0579US9029357B2Benzazole derivatives as histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2014·Granted May 12, 2015·4 cites·9 claims
- 0677US8354430B2Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidineBIOPROJET SOC CIV·Filed 2012·Granted Jan 15, 2013·3 cites·6 claims
- 0774US8802678B2Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligandsCAPET MARC·Filed 2007·Granted Aug 12, 2014·3 cites·14 claims
- 0873US8802664B2Benzazole derivatives as histamine H4 receptor ligandsBERREBI-BERTRAND ISABELLE·Filed 2011·Granted Aug 12, 2014·4 cites·11 claims
- 0971US12134608B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2022·Granted Nov 5, 2024·0 cites·18 claims
- 1070US12059416B2Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereofBIOPROJET SOC CIV·Filed 2021·Granted Aug 13, 2024·0 cites·5 claims
- 1168US9439853B2Form of administration of enkephalinase inhibitorJULIEN JEAN-STËPHANE·Filed 2011·Granted Sep 13, 2016·3 cites·17 claims
- 1267US8076329B2Histamine H3-receptor ligands and their therapeutic applicationsBERTRAND ISABELLE·Filed 2006·Granted Dec 13, 2011·2 cites·12 claims
- 1365US7138413B1Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applicationsILE BIOPROJET SOC CIV·Filed 1999·Granted Nov 21, 2006·19 cites·38 claims
- 1460US6248765B1Imidazole derivatives as histamine receptor H3 (ANT) agonistsINST NAT SANTE RECH MED·Filed 1996·Granted Jun 19, 2001·24 cites·93 claims
- 1558US11229632B2Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereofBIOPROJET SOC CIV·Filed 2019·Granted Jan 25, 2022·0 cites·4 claims
- 1656US11306069B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2018·Granted Apr 19, 2022·0 cites·13 claims
- 1755US10952987B2Combination of adrenalin with an antidepressant for use in the treatment of shocksBIOPROJET SOC CIV·Filed 2018·Granted Mar 23, 2021·0 cites·10 claims
- 1852US2011281844A1Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applicationsSCHWARTZ JEAN-CHARLES·Filed 2010·Application pending·0 cites
- 1949US2015306065A1A Combination of Adrenaline with an Antidepressant for Use in the Treatment of ShocksBIOPROJET SOC CIV·Filed 2013·Application pending·0 cites
- 2044US8017646B2Histamine H3-receptor ligands and their therapeutic applicationBIOPROJET SOC CIV·Filed 2006·Granted Sep 13, 2011·0 cites·13 claims
- 2142US9242959B2(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applicationsBIOPROJET SOC CIV·Filed 2013·Granted Jan 26, 2016·0 cites·14 claims
- 2233US2012129892A1Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical usesCAPET MARC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xavier Ligneau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →